December 5, 2017

Stocks In News - USFDA

 USFDA

  1. Aurobindo Pharma gets US FDA nod for Quetiapine Fumarate (50-400 mg) tablets (used to treat schizophrenia)
  2. Mylan and Biocon
    US FDA approves Mylan and Biocon's Ogivri, the first biosimilar for Trastuzumab, for the treatment of HER2-positive breast and gastric cancers


No comments:

Post a Comment